SCHEMBL13111167

SCHEMBL13111167

[C-]#[N+]c1ccc(S(=O)(=O)Nc2ccc3c(c2)B(C)OC3)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
LMNA P02545 5/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
THRB P10828 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
HTR6 P50406 5/20 0.38
DRD2 P14416 4/20 0.38
DRD3 P35462 4/20 0.38
POLB P06746 1/20 0.37
HTR2A P28223 3/20 0.36
HTR2C P28335 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
DPP4 P27487 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13111158 0.88 ALDH1A1 (0.38) ALDH1A1LMNASMN1; SMN2THRBL3MBTL1
SCHEMBL13111481 0.86 CA1 (0.49)
SCHEMBL10172234 0.84 HTR6 (0.50) ALDH1A1LMNASMN1; SMN2GAAHTT
SCHEMBL13111162 0.82 ALDH1A1 (0.59) ALDH1A1LMNAGAAMEN1MAPT
SCHEMBL13111180 0.82 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2THRBL3MBTL1
SCHEMBL13111154 0.81 DRD2 (0.45) ALDH1A1LMNASMN1; SMN2THRBL3MBTL1
SCHEMBL13111161 0.81 HTR6 (0.45) ALDH1A1LMNASMN1; SMN2THRBL3MBTL1
SCHEMBL13111155 0.81 CA12 (0.49) ALDH1A1LMNAGAAHTTPOLB
SCHEMBL13111156 0.79 FFAR4 (0.52) ALDH1A1LMNASMN1; SMN2DRD2DRD3
SCHEMBL13111620 0.78 CA1 (0.41) ALDH1A1LMNASMN1; SMN2GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256092-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256092-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD ALDH1A1 4190/4885LMNA 3490/4885SMN1; SMN2 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.